Catalyst Pharmaceuticals Inc (CPRX)
Return on assets (ROA)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 71,410 | 62,037 | 115,549 | 99,406 | 83,079 | 66,917 | 54,498 | 45,060 | 39,482 | 41,610 | 74,621 | 72,220 | 74,983 | 71,476 | 41,766 | 42,946 | 31,875 | 9,445 | -12,024 | -28,949 |
Total assets | US$ in thousands | 470,114 | 413,211 | 443,896 | 407,227 | 375,630 | 333,114 | 267,309 | 246,972 | 237,788 | 223,248 | 209,130 | 197,216 | 192,354 | 174,860 | 131,412 | 117,880 | 112,376 | 96,691 | 78,234 | 61,077 |
ROA | 15.19% | 15.01% | 26.03% | 24.41% | 22.12% | 20.09% | 20.39% | 18.24% | 16.60% | 18.64% | 35.68% | 36.62% | 38.98% | 40.88% | 31.78% | 36.43% | 28.36% | 9.77% | -15.37% | -47.40% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $71,410K ÷ $470,114K
= 15.19%
The return on assets (ROA) for Catalyst Pharmaceuticals Inc has shown a fluctuating trend over the past few quarters.
In the most recent quarter, the ROA stood at 15.19%, reflecting the company's ability to generate a profit relative to its total assets. Looking at the trend, we can observe that the ROA has generally been on an upward trajectory since the beginning of 2021 when it was 9.77%. The ROA peaked in the second quarter of 2021 at an impressive 40.88%, indicating a strong performance during that period.
The ROA then experienced a slight dip in the following quarters but remained at relatively healthy levels. Notably, in the second quarter of 2022 and the third quarter of 2022, the ROA rose above 20%, suggesting efficient asset utilization and profitability.
It's essential to highlight the significant improvement in ROA compared to the last three quarters of 2019 and 2020, where the company had negative ROA figures, indicating operational inefficiencies and potentially poor financial performance during that period.
Overall, the recent ROA figures demonstrate that Catalyst Pharmaceuticals Inc has been effectively managing its assets to generate profits, with the most recent quarters showing continued stability with ROA figures ranging from 15.01% to 26.03%.
Peer comparison
Dec 31, 2023